2000
DOI: 10.1002/1098-1004(200009)16:3<278::aid-humu29>3.0.co;2-g
|View full text |Cite
|
Sign up to set email alerts
|

A heterozygous novel C253Y mutation in the highly conserved cysteine residues of ROM1 gene is the cause of retinitis pigmentosa in a Spanish family?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 3 publications
(3 reference statements)
2
3
0
Order By: Relevance
“…Mir et al, 1997;Reig et al, 2000). An additional ROM1 stop-gain variant was identified in another individual in our cohort, c.339dup p.(Leu114Alafs*18), which was previously reported in literature as "most likely not pathogenic"(Boulanger-Scemama et al, 2015).…”
supporting
confidence: 75%
See 1 more Smart Citation
“…Mir et al, 1997;Reig et al, 2000). An additional ROM1 stop-gain variant was identified in another individual in our cohort, c.339dup p.(Leu114Alafs*18), which was previously reported in literature as "most likely not pathogenic"(Boulanger-Scemama et al, 2015).…”
supporting
confidence: 75%
“…For noncanonical splice site variants, near‐exon variants and DIVs, in silico tools Splice Site Finder‐like (Zhang, 1998 ), MaxEntScan (Yeo & Burge, 2004 ), NNSPLICE (Reese et al, 1997 ) and GeneSplicer (Pertea et al, 2001 ) were used in Alamut Visual software version 2.13 (Interactive Biosoftware) to predict the impact on splicing, using parameters described by Fadaie et al ( 2019 ), and ESEfinder (Cartegni et al, 2003 ) to predict effects on exon splicing enhancers (ESEs). SpliceAI (Jaganathan et al, 2019 ) was used via the BROAD Institute web interface tool ( https://spliceailookup.broadinstitute.org/ #) to further predict splicing effects, using a 10,000‐bp (5000‐bp upstream and 5000‐bp downstream) window.…”
Section: Methodsmentioning
confidence: 99%
“…Variants in ROM1 and the implication in IRDs are not completely understood. Heterozygous ROM1 variants have been reported with heterozygous PRPH2 variants to cause digenic RP [47] in addition to few putative associations of heterozygous ROM1 variants with adRP with incomplete penetrance [48,49]. An additional ROM1 stop-gain variant was identified in another individual in our cohort, c.339dup; p.(Leu114Alafs*18), which was previously reported in literature as ''most likely not pathogenic'' [50].…”
Section: Novel Findingssupporting
confidence: 63%
“…While evidence that ROM1 mutations alone may cause human visual pathology is limited (Bascom et al, 1995 ;Sakuma et al, 1995 ;Reig et al, 2000 ), photoreceptors of Rom1 -/mice eventually degenerate (Clarke et al, 2000 ). We propose that the delay in disc enclosure is the primary defect underlying this degeneration.…”
Section: Discussionmentioning
confidence: 83%
“…Around 200 mutations of PRPH2 are shown to cause a heterogeneous set of inherited retinal diseases, including retinitis pigmentosa, cone-rod dystrophy and macular dystrophies (Landrum et al, 2018 ;Peeters et al, 2021 ). Yet, mutations in ROM1 typically cause digenic retinitis pigmentosa in conjunction with mutations in PRPH2 (Kajiwara et al, 1994 ;Dryja et al, 1997 ), except for a handful of reports of mutations in ROM1 in patients without accompanying PRPH2 mutations (Bascom et al, 1995 ;Sakuma et al, 1995 ;Reig et al, 2000 ). With regard to animal models, the Prph2 knockout mouse, commonly known as the rds mouse, has a complete failure of outer segment formation (Cohen, 1983 ;Jansen and Sanyal, 1984 ), while the Rom1 knockout mouse forms outer segments with relatively minor structural abnormalities (Clarke et al, 2000 ).…”
Section: Introductionmentioning
confidence: 99%